NKG2D CAR T‐cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
NKG2D CAR T‐cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
About this item
Full title
Author / Creator
Publisher
United States: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
United States: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
Tumor heterogeneity presents a substantial barrier to increasing clinical responses mediated by targeted therapies. Broadening the immune response elicited by treatments that target a single antigen is necessary for the elimination of tumor variants that fail to express the targeted antigen. In this study, it is shown that adoptive transfer of T ce...
Alternative Titles
Full title
NKG2D CAR T‐cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3700668
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3700668
Other Identifiers
ISSN
0818-9641
E-ISSN
1440-1711
DOI
10.1038/icb.2013.17
